Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2020 · 10-Q
Revenue$2.48M$2.48M−4.9% vs Q2 2019 Net Income-$1.66M-$1.66MN/M vs Q2 2019 EPS Diluted-$0.11-$0.11N/M vs Q2 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,708,000N/M Margins · derivedGross margin67.6%
Operating margin-59.5%−9.9 pt vs Q2 2019
Net margin-67.0%−7.5 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end